Current Issue
Advanced Therapy Medicinal Products Technology Transfer Challenges – Part 3
Robert Dream, Managing Director, HDR Company LLC
Advances and Challenges in Vaccine Development and Manufacture
Tony D’Amore, Ph.D. MBA, Board Member, Scientific Advisor and Independent Consultant for...
Endotoxin Control Strategies for Parenteral Drug Product Manufacturing
Robert Simler, Associate Vice President, Process Development, Amgen (previously Associate ...
Current Trends in Control and Monitoring of Subvisible Particulate Matter in Biotherapeuti...
Satish (Kumar) Singh, Vice President, Drug Product Development, Astria Therapeutics, Inc. ...
Lifetime Study for JSR Amsphere A3 – Protein A Resin
JSR Life Sciences
Featured Articles
Bringing the Freezing of Biopharmaceuticals in From the Cold
Productivity and Economic Advantages of Coupling Single-Pass Tangential Flow Filtration to Multi-Column Chromatography for Continuous Processing
Mark Schofield, Ph.D., Karl Rogler, Xhorxhi Gjoka, Engin Ayturk, Ph.D., and René Gantier, Ph.D.
Bristol Myers Squibb adopts positive CHMP opinion for Opdivo plus Yervoy for patients with Microsatellite instability high or mismatch repair deficient metastatic colorectal cancer
Bristol Myers Squibb
Navigating Technology Transfer
View All Featured ArticlesHeadline News
FDA approves Johnson & Johnson’s IMAAVY as the first treatment ever cleared for warm autoimmune hemolytic anemia, marking a major step forward for patients
Abbott reaches settlement agreements resolving portion of litigation tied to specialty formulas for preterm infants
FDA approves Regeneron’s Pasatru the first treatment shown to reduce new heterotopic ossification lesions and clinician-assessed flare-ups in a placebo-controlled trial for adults with fibrodysplasia ossificans progressiva
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Operational Excellence in Process Development in Drug Substance Production
Presented by Ken Green, Ph.D, Head of Manufacturing, Science and Technology at Samsung Biologics, Klaus Mauch, CEO at Insilico Biotechnology AG
11th February 2021
Advances in the Purification of Antisense Oligonucleotides
Presented by Robert Gronke, Ph.D., Senior Principal Scientist, Technical Development, Biogen and John Cyganowski, Director of Customer Application, Downstream, Merck
27th October 2021
Safety Evaluation on Extractables and Leachable
Presented by Dr Clemens Günther, Senior Expert Nonclinical Safety, Director at Bayer AG, R&D Pharmaceuticals and Tino Otte, Head of Sales & Consulting at Intertek
25th October 2022
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
From Compliance to Circularity: Three Ways Pharma Manufacturers Can Rethink Resource Management
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
Caustic Stability of Amsphere A3 : Cycling Study with 0.5 M NaOH
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
